Transforming growth factor a (TGFa) shares with epidermal growth factor (EGF) structural homology (35%), a common cell-surface membrane receptor (TGFa/EGF receptor), and a nearly identical spectrum of biological activity, including inhibition of gastric acid secretion. Herein, we report expression of TGFa mRNA in normal gastric mucosa of the adult guinea pig, rat, and dog. TGFa mRNA was also detected in matched surgically resected gastric mucosa and adjacent gastric carcinoma from 10 patients, and in gastric mucosa adjacent to a benign ulcer from an additional patient. TGFa protein was quantitated by radioimmunoassay and was present in tumor and adjacent mucosa. TGFa/EGF receptor mRNA was also detected in gastric mucosa from all species studied. Localization of TGFa and TGFa/EGF receptor mRNA expression was examined in samples of unfractionated guinea pig gastric mucosa and from chief cell-enriched and parietal cell-enriched fractions. All samples exhibited TGFa and TGFa/EGF receptor expression. The TGFa signal was greatest in the parietal cell fraction (5.8-fold increase), but was also enhanced in the chief cell fraction (1.9-fold increase) relative to the unfractionated gastric mucosa. Like TGFa expression, TGFa/EGF receptor mRNA expression was most intense in the parietal cellenriched fraction (7.8-fold increase), but was also increased in the chief cell-enriched fraction (2.7-fold increase) relative to the unfractionated guinea pig gastric mucosa. We conclude that TGFa and TGFa/EGF receptor genes are expressed in normal adult mammalian gastric mucosa. These findings, when interpreted in light of described actions of TGFa and EGF, provide evidence that local production of TGFa could play an important role in the regulation of acid secretion and mucosal renewal in the stomach.
Introduction
Epidermal growth factor (EGF)' and transforming growth factor a (TGFa) are homologous polypeptides (1, 2), both of which bind to the EGF receptor (3) (4) (5) . TGFa was initially postulated to be an embryonic growth factor that was inappropriately expressed in neoplasia (6) . More recently, TGFa ex-pression has been detected in a number of nontransformed cells and tissues (7) (8) (9) . The spectrum of biological activity for TGFa and EGF are qualitatively similar, although several quantitative differences have been observed (10, 1 1). All known actions ofboth ligands appear to be mediated via binding to the TGFa/EGF receptor; no discrete TGFa receptor has been identified (12).
Both EGF and TGFa have been shown to have potent effects on the gastric mucosa, a complex epithelium composed of multiple cell types. Surface epithelial cells, which line the mucosa of all regions of the stomach, secrete mucus and bicarbonate. Parietal cells, which secrete hydrochloric acid, and chief cells, which secrete pepsinogen, are found primarily in gastric glands in the fundus and body. Neuroendocrine cells consist of gastrin-producing G-cells, somatostatin-producing D-cells, enterochromaffin cells and enterochromaffin-like cells; their distribution varies with the particular cell type, e.g., the stomach's G-cells are confined to the antrum (13) .
EGF stimulates DNA synthesis in the gastric mucosa of rodents (14) (15) (16) and protects against gastric ulcer formation in rats and cats at doses that have no effect on acid secretion ( 16) . Removal of salivary glands (the major intraluminal source of EGF) in rats results in atrophy of gastric mucosa (17) and a delay in healing ofgastric and duodenal ulcerations that can be reversed by treating the animals with either oral or parenteral EGF (18). These studies imply an important physiological role for EGF in gastric mucosal growth. Of potential importance in the stomach, both TGFa (19) and EGF (20) are acid stable proteins.
Extracts from human urine have long been known to inhibit gastric acid secretion (21, 22) . The putative gastric acid inhibitory agent was named urogastrone. Subsequent purification and characterization of human EGF (20, 21) and human f3-urogastrone (24) revealed that they were identical. In conscious dogs, EGF inhibits gastric acid secretion stimulated by pentagastrin, histamine, and urecholine, as well as that stimulated by meal and sham feeding (25) . In anesthetized rats, EGF inhibits gastric acid secretion stimulated by carbachol, histamine, and pentagastrin (26) . EGF (27) and TGFa (28) inhibit histamine-stimulated gastric acid secretion from isolated guinea pig gastric mucosa when delivered to the serosal, but not luminal surface; intravenous delivery of both ligands inhibits acid secretion in rats (29) . In addition to inhibiting acid secretion, EGF inhibits pepsinogen secretion in rabbit gastric mucosa stimulated by agonists that increase intracellular cAMP (30) . High affinity TGFa/EGF binding sites have been demonstrated on both fundic and antral gastric glands from the guinea pig (31) .
TGFa is no longer regarded simply as an embryonic growth factor that is inappropriately expressed in neoplasia, but also as an integral physiological regulator of growth in normal tissues ( 12, 32, 33) . In screening gastrointestinal tissues for TGFa expression, we found relatively abundant levels in the gastric mucosa. Given the aforementioned effects ofTGFa and EGF on gastric mucosal growth, repair, and acid secretion, we examined gastric mucosa from four mammalian species for TGFa, EGF, and TGFa/EGF receptor expression and attempted to localize expression to a subpopulation of gastric mucosal cells.
Methods
Processing oftissue. Gastric mucosa was obtained from normal adult mongrel dogs, guinea pigs, and rats at sacrifice and kidneys were obtained from rats and dogs. Human gastric and kidney samples were obtained fresh from the Department of Surgical Pathology. Human gastric carcinoma and adjacent uninvolved gastric mucosa were also obtained from the Cooperative Human Tissue Network of the National Cancer Institute and from the Mayo Clinic (Rochester, MN). The gastric mucosa was washed with cold water and then rapidly dissected from the muscularis. The samples were rapidly frozen in liquid nitrogen and stored at -80°C until processing. Human tissue utilization was approved by Vanderbilt University and Mayo Clinic Institutional Review Boards.
Method of obtaining enriched cell fractions. Female guinea pigs (200-250 g), strain 2, were obtained from the National Cancer Institute (Frederick, MD). Enriched populations of guinea pig chief cells and parietal cells were obtained as described previously (34) . In brief, the mucosa of gastric fundus and antrum was incubated in standard incubation solution containing 0.1% collagenase for 30 min at 37°C and gassed with 100% oxygen. Single cells were formed by incubating with 2 mM EGTA, dispersed by syringe and fractionated on a Percoll density gradient (d 1.065 g/ml). At least 300 cells were counted and each cell type was determined as a percentage of the total cell population counted. The cell populations obtained have been characterized previously by Papanicolaou, PAS, and immunofluorescent staining (34) .
In agreement with the previous report (34) , the least dense fraction (density less than 1.040 g/ml) of guinea pig gastric mucosal cells was enriched with parietal cells, comprising 60-70% ofthat fraction's cells. It has previously been shown that this fraction is depleted of chiefcells (34) . The fractions migrating between 1.060 and 1.080 g/ml were highly enriched with chief cells, containing -95% chief cells. The yield of cells in these fractions varied among cell preparations, ranging from 1.0-1.5 X 107 cells per stomach. Chief cells obtained from six stomachs and parietal cells from four stomachs were pooled and stored in guanidinium isothiocyanate buffer at -80°C.
RNA extraction and blotting. Total cellular RNA was prepared from excised tissues using a phenol extraction method as described previously (35) . Total cellular RNA from enriched cell fractions was prepared by homogenization in 4 M guanidinium isothiocyanate and pelleted through a cesium chloride cushion by ultracentrifugation (36) . Polyadenylated (poly A) RNA was isolated with oligo (dT) cellulose (Collaborative Research Inc., Bedford, MA). RNA was electrophoretically separated on a formaldehyde/1.2% agarose gel (37) and blotted onto nitrocellulose as described (38) .
The TGFa clone is a human 1.27-kb cDNA encompassing the entire open reading frame as well as 0.79-kb of flanking 3' untranslated sequence (2) . The TGFa/EGF receptor clone is a human 0.889-kb cDNA that encompasses the COOH-terminal 198 codons plus 290 base pairs of 3' untranslated cDNA (39) . The probes were subcloned into plasmid SP65 and labeled with [a-32P]UTP as described (40) .
Hybridization and posthybridization washes were carried out at 65°C as previously described (41) . A human EGF cDNA probe was kindly provided by Graeme Bell (42) , and an Eco RI insert was labeled by a random primer extension method (43 (Fig. 1) . TGFa mRNA was also detected in the gastric mucosa of normal adult rats (data not shown). In the dog, there was relatively more TGFa mRNA expression (approximately fourfold) in the antral mucosa than in the fundic mucosa (Fig. 2) . Similar graph. The TGFa transcript was not detectable in the remaining human gastric submucosal samples (data not shown).
Thus, in the species examined, TGFa expression is largely localized to the epithelial compartment of the stomach. The blot depicted in Fig. 2 was also probed with a 32P-labeled human EGF cDNA probe (Fig. 3) . At a 48-h exposure, the 5.2-kb EGF signal was detected in the dog fundus but not the antrum. This differential localization of EGF within the dog gastric mucosa was confirmed in a second dog. The EGF signals detected at 48 h in the kidney samples were overexposed relative to those seen in the fundus and antrum. A shorter exposure (6 h) showed the EGF transcripts in the dog and human kidney samples more clearly (Fig. 3 ). An EGF transcript has not been detected, even after prolonged exposure, in any gastric mucosal samples from humans, guinea pigs, or rats (data not shown).
Localization of TGFa and TGFa/EGF receptor mRNA expression within the gastric mucosa was determined using (Fig. 4 A) and TGFa/EGF receptor (Fig. 4 B) . Visual inspection of the ethidium bromide-stained gels under ultraviolet light revealed near-equal RNA loading, and the intensities of the TGFa and TGFa/EGF receptor signals were determined by laser densitometry after normalizing to the intensities of the respective 28S ribosomal RNA bands (data not shown). The TGFa signal was greatest in the parietal cell fraction (5.8-fold increase), but was also enhanced in the chief cell fraction (1.9-fold increase) relative to the unfractionated gastric mucosa (Fig. 4 A) . The 10-kb TGFa/EGF receptor transcript was observed in all three samples (Fig. 4 B) . As with TGFa expression, the TGFa/EGF receptor expression was most intense in the parietal cellenriched fraction (7.8-fold increase), but was also increased in the chief cell-enriched fraction (2.7-fold increase) compared to the unfractionated guinea pig gastric mucosa. TGFa/EGF receptor mRNA expression was also detected in the gastric mucosa of dogs and man in which cell enrichment was not performed (data not shown). Samples of gastric mucosa were obtained from ten patients (Fig. 5, patients 2-1 1) . These specimens contained matched tumor (C) and adjacent uninvolved gastric mucosa (N). The primary tumor sites were variable from the cardia to the pylorus, but the site did not appear to influence the level of TGFa expression (data not shown). An from all specimens showed TGFa expression. Visual inspection of an ethidium bromide-stained gel showed near-equal intensity of ribosomal RNA bands within the paired samples (data not shown). In four paired samples (Nos. 3, 4, 6, 7), there was no apparent increase in expression of TGFa mRNA in tumor compared to adjacent mucosa, but in patients 2, 5, 8, 9, 10, and 11 there appeared to be an increase in TGFa expression in the tumor relative to the matched mucosa. All of the four tumor samples in which no increase of TGFa expression was seen compared to adjacent mucosa were histologically poorly differentiated tumors. Five of the six tumor samples that have increased TGFa expression relative to adjacent mucosa are either well or moderately differentiated on histological grading. Selected samples (Nos. 3, 6, 7, 9-1 1) were also processed for TGFa protein analysis using a radioimmunoassay kit and these data are presented in Table I . TGFa protein was detected in all samples and amounts were comparable among the samples; however, there was not a good correlation between intensity of TGFa mRNA signal and amounts of protein detected.
Discussion
TGFa and EGF may function in maintaining gastric mucosal integrity by promoting cell migration, stimulating cellular proliferation, and suppressing acid production. In support of this, epithelialization of experimentally induced gastric ulcers occurs at a rate faster than can be accounted for by mitosis (46) and rapid migration ofgastric epithelial cells to cover the ulcer has been shown (47) (48) (49) . TGFa and EGF stimulate a rapid migration of proliferating keratinocytes in culture which results in expansion of colony size at a rate faster than can be accounted for by mitosis (50). Furthermore, EGF promotes (by up to 100-fold) directed migration of cultured intestinal epithelial cells (51). In addition to its effects on cell migration, EGF (and presumably TGFa) stimulate rat oxyntic gland DNA synthesis (15) and gastric mucosal growth (18, 52). Suppression of gastric acid secretion is another biological effect of EGF (21, 22, 24) . TGFa and EGF are equipotent in suppressing acid secretion from guinea pig gastric mucosa in vitro (28) and from rats in vivo (29) . Our demonstration of expression of TGFa and its receptor throughout the gastric mucosa invites speculation that the local production of TGFa could mediate these effects and thus participate in the stomach's defense against mucosal injury by decreasing acid secretion, while simultaneously stimulating cell migration and later proliferation. The highest level of TGFa expression is localized to the epithelial compartment of the stomach and very little or none is detected in the gastric submucosa. Our demonstration of increased TGFa and TGFa/EGF receptor mRNA expression in parietal cell-enriched fractions from the guinea pig stomach, together with a preliminary description of specific TGFa/EGF binding sites on isolated canine parietal cells (53) , support direct regulation of parietal cell acid secretion by TGFa as well as EGF. Thus, evidence is presented for a new pathway for modulation of gastric acid secretion, i.e., paracrine and/or autocrine regulation by locally produced TGFa. The finding of TGFa and TGFa/EGF receptor expression in the chief cellenriched fraction is provocative since EGF has been reported to inhibit pepsinogen secretion in rabbit gastric mucosa (30) . In the dog, TGFa mRNA expression was greater in antral versus fundic mucosa. This observation was surprising in view of the high levels of TGFa mRNA expression in guinea pig parietal cells, which predominate in the fundus. One possible explanation for this paradoxical finding would be the presence of increased mRNA expression in cells found preferentially in the gastric antrum, perhaps the gastrin producing G-cell population (54). To assess expression of TGFa in canine G-cells, Northern blot analysis of a purified population of G-cells and/ or in situ hybridization studies will be required. The increased expression of TGFa in the dog antrum relative to fundus was not seen in the human samples. This may be a species difference, or may be due to the fact that the human samples were obtained from patients with gastric pathology.
Examination of the human samples suggests that there is a trend toward increased expression of TGFa mRNA in tumors compared to adjacent mucosa in those cases in which the tumors have a histological grade less than poorly differentiated, but the sample size is insufficient to draw firm conclusions. Like its mRNA, TGFa protein was detected in all samples examined, but there was not a good correlation between intensity of message and amount of protein. Possible explanations for this discrepancy include a variation in the site of sampling, transport, and excretion of TGFa, or posttranscriptional regulation. TGFa species detected in cell extracts from various sources display heterogeneity in molecular weights, which may be due to the presence of larger N-glycosylated forms of TGFa that are released after proteolytic cleavage of the transmembrane TGFa precursor (55) . The antibody used for the radioimmunoassay may not recognize these larger glycosylated forms and could lead to an underestimation of TGFa protein levels. What can be concluded with confidence is that TGFa mRNA and protein are present in human gastric carcinomas and adjacent noncancerous mucosa, the latter finding being consistent with results obtained from normal gastric mucosa of the other mammalian species in the present study. Clearly, TGFa expression is not restricted to neoplastic tissue.
Whereas TGFa mRNA expression was detected in gastric mucosa from all four species studied, weak EGF mRNA expression was detected in the fundic mucosa of the dog only. The explanation for this species difference and regional distribution of EGF expression within the dog gastric mucosa is not apparent. Previous studies have shown EGF immunoreactivity in the human gastric mucosa (56). We did not detect EGF mRNA in human gastric mucosa from surgically resected tissue; however, these samples were adjacent to a tumor or a benign ulcer and may not be representative of normal healthy mucosa. The samples from guinea pig, rat, and dog, however, do represent healthy mammalian gastric mucosa. If there is little or no EGF mRNA and consequently little or no protein produced in the gastric mucosa, then what has been detected in the past by immunological methods (18, 56) may be produced more proximally in the alimentary tract. For example, swallowed EGF secreted from the salivary glands may become bound to gastric mucosal cell receptors, internalized, and thus detected as immunoreactivity.
The present study demonstrates expression of TGFa and its receptor throughout the gastric mucosa in four mammalian species, including man. These observations, when coupled to described actions of EGF and TGFa, implicate locally produced TGFa in regulation of gastric acid secretion and in cell renewal after injury to the gastnrc mucosa.
